BOOK REVIEW
| Journal | Volume 68 - 2005 |
| Issue | Fasc.3 - Book review |
| Author(s) | A.P. Geubel. |
| Full article |
 VIEW FREE PDF |
| Rifaximin : A Poorly Absorbed Antibiotic. Pharmacology and Clinical Use. Scarpignato C. (Edited by -). Karger, Basel, 2005. |
|
Rifaximin is a semisynthetic rifamycin first described in1982. It is minimally absorbed by the normal gas- trointestinal tract and which has been recently approved by the FDA in the US for the treatment of traveler's diar- rhea. In Europe, it is likely available only into the italian market. Its antimicrobial activity is broad, mainly against gram-positive bacteria including oxacillin- resistant strains of Staphylococcus aureus, C. difficile and Helicobacter pylori. |
|
© Acta Gastro-Enterologica Belgica. |